Jeevan Scienti.

{
  "main_header": {
    "sid": 300069,
    "name": "Jeevan Scienti.",
    "stock_name": "Jeevan Scienti.",
    "full_name": "Jeevan Scientific Technology Ltd",
    "name_url": "stocks-analysis/jeevan-scienti",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "68.61",
    "chg": -1.4,
    "chgp": "-2.0%",
    "dir": -1,
    "prev_price": "70.01",
    "mcapval": "111.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538837,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE237B01018",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": "5.63 k",
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jeevan-scienti-300069-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Jeevan Scientific Technology Ltd Reports Strong Quarterly Financial Turnaround",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jeevan-scientific-technology-ltd-reports-strong-quarterly-financial-turnaround-3834003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JeevanScientifi_fintrenddot_3834003.png",
        "date": "2026-02-12 08:00:14",
        "description": "Jeevan Scientific Technology Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, reversing a previously flat trend to deliver robust revenue growth and margin expansion. The healthcare services company posted its highest quarterly net sales and profitability metrics in recent history, signalling a potential turnaround in operational efficiency and market positioning."
      },
      {
        "title": "Are Jeevan Scientific Technology Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jeevan-scientific-technology-ltd-latest-results-good-or-bad-3833453",
        "imagepath": "",
        "date": "2026-02-11 19:37:03",
        "description": "Jeevan Scientific Technology Ltd's latest financial results for Q3 FY26 indicate a notable operational turnaround, as the company returned to profitability with a consolidated net profit of ₹1.42 crores, contrasting with a loss of ₹0.09 crores in the previous quarter. This recovery is underscored by a significant revenue growth of 54.04% quarter-on-quarter and 52.44% year-on-year, reaching a record net sales figure of ₹19.07 crores. The operating profit margin also improved to 27.43%, marking the best performance in four quarters, which suggests enhanced operational efficiency and a favorable project mix.\n\nDespite these positive developments, the company continues to face challenges, as it remains loss-making on a trailing twelve-month basis. The average return on equity (ROE) of 9.56% indicates weak capital efficiency, and the latest ROE has turned negative at -9.28%, reflecting the impact of previous loss..."
      },
      {
        "title": "Jeevan Scientific Q3 FY26: Strong Revenue Surge Masks Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/jeevan-scientific-q3-fy26-strong-revenue-surge-masks-profitability-concerns-3833297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JeevanScientifi_quaterlyResult_3833297.png",
        "date": "2026-02-11 17:46:38",
        "description": "Jeevan Scientific Technology Ltd., a clinical contract research organisation, delivered a remarkable 54.04% quarter-on-quarter revenue surge in Q3 FY26, posting net sales of ₹19.07 crores against ₹12.38 crores in Q2 FY26. However, the company's consolidated net profit of ₹1.42 crores, whilst positive, reflects ongoing profitability challenges that have plagued the micro-cap healthcare services firm. With a market capitalisation of ₹110.00 crores, the stock traded at ₹70.01 on February 11, 2026, up 1.10% from the previous close."
      },
      {
        "title": "Jeevan Scientific Technology Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jeevan-scientific-technology-ltd-is-rated-sell-3828273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JeevanScientifi_mojoScore_3828273.png",
        "date": "2026-02-09 10:11:11",
        "description": "Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Why is Jeevan Scientific Technology Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jeevan-scientific-technology-ltd-fallingrising-3825426",
        "imagepath": "",
        "date": "2026-02-07 00:43:38",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Short-Term Price Momentum and Market Outperformance</strong></p>\n<p>Jeevan Scientific Technology Ltd has demonstrated notable resilience in the short term, with a one-week return of 12.01%, significantly outperforming the Sensex’s 1.59% gain over the same period. Year-to-date, the stock has appreciated by 5.48%, while the Sensex has declined by 1.92%. This positive momentum is further underscored by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling robust technical support and investor confidence.</p>\n<p>On 06-Feb, the stock touched an intraday high of Rs 67.99, maintaining a narrow trading range of just Rs 0.01, which suggests a consolidation phase with limited volatility. However, it is important to note t..."
      },
      {
        "title": "Jeevan Scientific Technology Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jeevan-scientific-technology-ltd-is-rated-sell-3809066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JeevanScientifi_mojoScore_3809066.png",
        "date": "2026-01-29 10:11:07",
        "description": "Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jeevan Scientific Technology Ltd Hits New 52-Week High at Rs.76.99",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jeevan-scientific-technology-ltd-hits-new-52-week-high-at-rs7699-3785378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JeevanScientifi_priceRelatedfactors_3785378.png",
        "date": "2026-01-08 10:00:43",
        "description": "Jeevan Scientific Technology Ltd, a key player in the Healthcare Services sector, reached a significant milestone today by hitting a new 52-week high of Rs.76.99. This achievement marks a continuation of the stock’s robust upward momentum, reflecting sustained gains over recent sessions and outperforming its sector peers."
      },
      {
        "title": "Jeevan Scientific Technology Ltd Hits New 52-Week High of Rs.75.02",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jeevan-scientific-technology-ltd-hits-new-52-week-high-of-rs7502-3784128",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JeevanScientifi_priceRelatedfactors_3784128.png",
        "date": "2026-01-07 09:44:55",
        "description": "Jeevan Scientific Technology Ltd, a key player in the Healthcare Services sector, reached a significant milestone today by hitting a new 52-week high of Rs.75.02. This achievement underscores the stock’s robust momentum, driven by sustained gains over recent sessions and strong market positioning."
      },
      {
        "title": "Jeevan Scientific Technology Ltd Hits New 52-Week High at Rs.71.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jeevan-scientific-technology-ltd-hits-new-52-week-high-at-rs7145-3783200",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JeevanScientifi_priceRelatedfactors_3783200.png",
        "date": "2026-01-06 10:16:47",
        "description": "Jeevan Scientific Technology Ltd, a key player in the Healthcare Services sector, reached a significant milestone today by hitting a new 52-week high of Rs.71.45. This achievement marks a continuation of the stock’s strong upward momentum, reflecting sustained gains over recent sessions and outperforming its sector peers."
      }
    ],
    "total": 117,
    "sid": "300069",
    "stock_news_url": "https://www.marketsmojo.com/news/jeevan-scientific-technology-300069"
  },
  "announcements": [
    {
      "caption": "Closure Of The United States Food And Drug Administration (US FDA) Remote Regulatory Assessment Of JSTL And Issuance Of The Remote Regulatory Assessment Report - Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "22-Jan-2026",
      "details": "Disclosure under Regulation 30 of (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jan-2026",
      "details": "Compliances as per Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "07-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Padmaja Private Trust",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jeevan Scientific Technology Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 22",
          "dt": "2022-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jeevan Scientific Technology Ltd Reports Strong Quarterly Financial Turnaround

2026-02-12 08:00:14

Jeevan Scientific Technology Ltd has demonstrated a marked improvement in its financial performance for the quarter ended December 2025, reversing a previously flat trend to deliver robust revenue growth and margin expansion. The healthcare services company posted its highest quarterly net sales and profitability metrics in recent history, signalling a potential turnaround in operational efficiency and market positioning.

Read full news article

Are Jeevan Scientific Technology Ltd latest results good or bad?

2026-02-11 19:37:03

Jeevan Scientific Technology Ltd's latest financial results for Q3 FY26 indicate a notable operational turnaround, as the company returned to profitability with a consolidated net profit of ₹1.42 crores, contrasting with a loss of ₹0.09 crores in the previous quarter. This recovery is underscored by a significant revenue growth of 54.04% quarter-on-quarter and 52.44% year-on-year, reaching a record net sales figure of ₹19.07 crores. The operating profit margin also improved to 27.43%, marking the best performance in four quarters, which suggests enhanced operational efficiency and a favorable project mix. Despite these positive developments, the company continues to face challenges, as it remains loss-making on a trailing twelve-month basis. The average return on equity (ROE) of 9.56% indicates weak capital efficiency, and the latest ROE has turned negative at -9.28%, reflecting the impact of previous loss...

Read full news article

Jeevan Scientific Q3 FY26: Strong Revenue Surge Masks Profitability Concerns

2026-02-11 17:46:38

Jeevan Scientific Technology Ltd., a clinical contract research organisation, delivered a remarkable 54.04% quarter-on-quarter revenue surge in Q3 FY26, posting net sales of ₹19.07 crores against ₹12.38 crores in Q2 FY26. However, the company's consolidated net profit of ₹1.42 crores, whilst positive, reflects ongoing profitability challenges that have plagued the micro-cap healthcare services firm. With a market capitalisation of ₹110.00 crores, the stock traded at ₹70.01 on February 11, 2026, up 1.10% from the previous close.

Read full news article

Jeevan Scientific Technology Ltd is Rated Sell

2026-02-09 10:11:11

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Why is Jeevan Scientific Technology Ltd falling/rising?

2026-02-07 00:43:38

Strong Short-Term Price Momentum and Market Outperformance

Jeevan Scientific Technology Ltd has demonstrated notable resilience in the short term, with a one-week return of 12.01%, significantly outperforming the Sensex’s 1.59% gain over the same period. Year-to-date, the stock has appreciated by 5.48%, while the Sensex has declined by 1.92%. This positive momentum is further underscored by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling robust technical support and investor confidence.

On 06-Feb, the stock touched an intraday high of Rs 67.99, maintaining a narrow trading range of just Rs 0.01, which suggests a consolidation phase with limited volatility. However, it is important to note t...

Read full news article

Jeevan Scientific Technology Ltd is Rated Sell

2026-01-29 10:11:07

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jeevan Scientific Technology Ltd Hits New 52-Week High at Rs.76.99

2026-01-08 10:00:43

Jeevan Scientific Technology Ltd, a key player in the Healthcare Services sector, reached a significant milestone today by hitting a new 52-week high of Rs.76.99. This achievement marks a continuation of the stock’s robust upward momentum, reflecting sustained gains over recent sessions and outperforming its sector peers.

Read full news article

Jeevan Scientific Technology Ltd Hits New 52-Week High of Rs.75.02

2026-01-07 09:44:55

Jeevan Scientific Technology Ltd, a key player in the Healthcare Services sector, reached a significant milestone today by hitting a new 52-week high of Rs.75.02. This achievement underscores the stock’s robust momentum, driven by sustained gains over recent sessions and strong market positioning.

Read full news article

Jeevan Scientific Technology Ltd Hits New 52-Week High at Rs.71.45

2026-01-06 10:16:47

Jeevan Scientific Technology Ltd, a key player in the Healthcare Services sector, reached a significant milestone today by hitting a new 52-week high of Rs.71.45. This achievement marks a continuation of the stock’s strong upward momentum, reflecting sustained gains over recent sessions and outperforming its sector peers.

Read full news article

View All News